To compare 1-year clinical efficacy of ( 1 ) initial triple disease-modifying antirheumatic drug therapy ( iTDT ) with initial methotrexate ( MTX ) monotherapy ( iMM ) and ( 2 ) different glucocorticoid ( GC ) bridging therapies : oral versus a single intramuscular injection in early rheumatoid arthritis .